Peter Mac Research
@PeterMacRes
Followers
4K
Following
958
Media
235
Statuses
2K
Cancer-dedicated research workforce @PeterMacCC. Committed to better treatments, care and cures for cancer
Parkville, Melbourne, Australia
Joined April 2019
Haematology registrar @PeterMacCC @eddiecliff has co-authored an important publication reviewing 20 years of RCT for #myeloma. Read more here
oncodaily.com
Eddie Cliff: Reviewing 20 Years of RCTs in Myeloma for Lessons in Drug Development / Alissa Visram, Aniko Szabo, cancer, Eddie Cliff, Edward R. Scheffer
0
0
2
For #BreastCancerAwarenessMonth, @CureCancerAu is highlighting Dr. Luis Lara Gonzalez. His work, supported by Cure Cancer, is uncovering how HER2-positive breast cancers resist treatment—& driving more precise, personalised therapies. More: https://t.co/68lO6esBBw
0
0
1
A world-first clinical trial at Peter Mac has found that a simple nasal spray can significantly reduce the risk of COVID-19 in cancer patients. Research published today showed the spray reduced the risk of COVID-19 infection by 40%. Read more here - https://t.co/TmCxhLLpE8
0
1
3
A discovery by researchers at Peter Mac shows that blocking a protein called CDK11 can result in the rapid death of cancer cells - a finding that's described as potentially the 'Achilles' heel of conditions like acute myeloid leukaemia (AML) Read more - https://t.co/OsD9Qvq1Yg
0
1
5
The 'Faces of Discovery' exhibition is showcasing some of the amazing researchers at Peter Mac to help celebrate National Science Week! The posters are on display in our Welcome Hall and on Level 7 at Peter Mac or you can go to our website to learn more - https://t.co/wQY72xU56Q
0
0
2
Join Peter Mac’s Research Student Open Day to meet supervisors, chat with students & explore projects. 📅 27 Aug, 4:30pm 📍 Peter MacCallum Cancer Centre 👉 Register now: https://t.co/rPD2nMUUKk
0
3
3
$4.8M in #MRFF funding powers new genomic research at Peter Mac by A/Profs @LEForrest, @DrKaraBritt and Prof Paul James. More: https://t.co/TgSZb83ZOg
0
4
14
Peter Mac trial suggests a way to dramatically improve outcomes in patients with high-risk forms of large B-cell lymphoma. 💊 Standard chemo + new drug glofitamab ✅ 98% complete response 🔒 86% progression-free at ~2 years 📈 92% overall survival MORE: https://t.co/ElAKltLLQv
0
2
6
Peter Mac’s Prof @MAF_Dawson has won the 2025 @ASH_hematology William Dameshek Prize – the first Australian to receive this top honour for his world-leading work in epigenetics. More: https://t.co/OF6ESOAmbw
0
1
21
Ground-breaking, practice-changing research from Prof Danny Rischin & Prof Sandro Porceddu @PeterMacCC and brilliant team of 🌏investigators. 👏 Excellent results for patients with high-risk SCC of skin, presented at #ASCO25 @ASCO Full results @NEJM ➡️ https://t.co/olCGEA9B6h
0
6
15
A record number of Peter Mac researchers presented at #ASCO25 — with global-impact trials, theranostics leadership, ctDNA breakthroughs & more. 🌍 “Our presence is getting bigger and more impactful each year.” – Prof Jayesh Desai. Read more: https://t.co/zkVo3kffoU
4
8
38
An experimental therapy involving radioactive Terbium, and designed to seek out and kill prostate cancer cells wherever they are in the body, has shown very positive initial results in a first-in-human clinical trial at Peter Mac. Read more:
petermac.org
#VIOLET Study of Terbium-161 (Tb-161) Beta/Auger therapy @ASCO #ASCO25 First prospective trial of Terbium-161 in any tumour type 🟣 30 patient trial in prostate cancer. No dose limiting toxicities at highest level of radioactivity (7.4 GBq) 🟣 Very few side effects: 1 grade 3
1
5
15
Don't miss the first-in-human VIOLET study being presented #ASCO25 @ASCO Monday June 2 3:00 PM New Frontiers in Prostate-Specific Membrane Antigen Radioligand Therapy (awesome research being presented in this session - don't miss the other talks) In press @TheLancetOncol
0
20
56
More practice changing research coming out of @PeterMacCC presented @ASCO2025. With a simultaneous publication in @NEJM 🙌 https://t.co/4qAvqGaIu4
dailynews.ascopubs.org
Adjuvant cemiplimab is associated with a significant reduction in the risk of disease recurrence in patients with high-risk CSCC after surgery and postoperative radiotherapy, according to results...
0
1
9
Applications are now open for this unique opportunity to undertake a 2-year clinical fellowship based between two world leading centres, @TheChristieNHS in the UK and @PeterMacCC in Australia. Find out more and apply: https://t.co/HjdWYdcald
0
3
3
Australia completely lacks a dedicated training program for clinician scientists. With the vision and support of VMIAL @PeterMacCC is extremely proud to announce the first clinician-scientist fellowship. If you meet the eligibility criteria PLEASE APPLY! https://t.co/Pkihh7c1uy
nature.com
Peter Mac is launching Australia’s first clinician-scientist fellowship to advance cancer care, fostering innovation and global collaboration.
9
21
76
An electric first day at the 2025 #PeterMacResearch Symposium ⚡ 400+ scientists & clinicians gathered to explore Future Tech & Patient-Centred Innovations. A powerful mix of collaboration, curiosity & cutting-edge thinking. 🧵 Highlights below 👇
1
4
11
He's done it!! Gamini cycled 5000kms over 42 days - crossing the entire continent from Perth to Brisbane. Crossing the finish line on election day, he raised over $21K for cancer research at Peter Mac. Read more about this incredible feat: https://t.co/qxQ3W2GykU
0
1
12
With a grant from the @MarkHughesFdn, @PeterMacRadOnc's Dr Neda Haghighi will explore if using three smaller pre-surgery doses of radiotherapy (rather than one) can lead to better outcomes & less impact on quality of life in secondary brain cancer. More: https://t.co/jpYOwx7wM2
1
5
14
Congrats to A/Prof @shomgoel, has today been awarded the Gottschalk Medal from @Science_Academy! His research is reshaping how we treat and understand #breastcancer. A huge honour and well deserved. 👏 🔗 https://t.co/5lTSIjPyaI
0
5
31